BearDownAZ's Recent Posts
Title ▲ Rating Company Posted on
Bromodomain-2 Selective BET inhibitors 6 Resverlogix Corp. Apr 19, 2018 10:35AM
Bromodomain-containi... proteins in prostate cancer 2 Zenith Epigenetics Feb 05, 2019 10:37AM
Bromodomains: a new target class for drug development 6 Resverlogix Corp. Jul 16, 2019 07:18AM
BTI 2 Resverlogix Corp. Nov 23, 2015 11:25AM
CANTOS and CIRT 5 Resverlogix Corp. Nov 10, 2017 04:30PM
CANTOS good, but FDA not on board with sub-group analysis 6 Resverlogix Corp. Oct 18, 2018 02:03PM
Cardiovascular organ damage in T2DM: the role of lipids and inflammation 5 Resverlogix Corp. May 11, 2019 08:20AM
Clarification on BETonMACE baseline data 10 Resverlogix Corp. Sep 04, 2019 12:43PM
Clinical Steering Committee meeting for BETonMACE? 5 Resverlogix Corp. Aug 24, 2018 09:54AM
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications 5 Resverlogix Corp. Jul 19, 2018 02:44PM
Colchicine....strong support of inflammation hypothesis 6 Resverlogix Corp. Aug 31, 2020 12:28PM
COLCORONA trial: Colchicine reduces the risk of COVID-19-related complications 4 Resverlogix Corp. Jan 23, 2021 11:06AM
Collection of ERA-EDTA and ESC Resverlogix Sponsored Symposia Videos 10 Resverlogix Corp. Aug 15, 2019 02:38PM
Compilation of BET inhibitor Trials 7 Resverlogix Corp. Oct 05, 2017 01:13PM
Compilation of BET inhibitor Trials 5 Zenith Epigenetics Oct 05, 2017 01:21PM
Compliment in Human Disease meeting at end of this month 3 Resverlogix Corp. Jun 18, 2015 03:51PM
Compounds and Autoimmune 8 Zenith Epigenetics Jun 21, 2016 12:10PM
Compounds and Autoimmune 5 Resverlogix Corp. Jun 21, 2016 12:12PM
Constellation Pharma news, courtesy of rndtbl 5 Zenith Epigenetics Nov 06, 2019 04:06PM
Constellation Pharmaceuticals Readies $80 Million IPO Plans 7 Zenith Epigenetics Jul 20, 2018 10:14AM